MD

Mikael Le Dantec

CEA: 1 patents #236 of 1,002Top 25%
Overall (2017): #306,867 of 506,227Top 65%
1
Patents 2017

Issued Patents 2017

Showing 1–1 of 1 patents

Patent #TitleCo-InventorsDate
9623015 Combination of an anti-cancer agent such as a tyrosinekinase inhibitor and a STAT5 antagonist, preferably a thiazolidinedione, for eliminating hematologic cancer stem cells in vivo and for preventing hematologic cancer relapse Stephane Prost, Marek Kirszenbaum, Philippe Rousselot, Philippe Leboulch 2017-04-18